¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"free insulin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • insulin-like growth factor
    Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
  • insulin-resistant diabetes
    Àν¶¸°ÀúÇ×´ç´¢º´
  • insulin-to-glucose ratio
    Àν¶¸°´ëÆ÷µµ´çºñ
  • intermediate-acting insulin
    Áß°£ÀÛ¿ëÀν¶¸°
  • long acting insulin
    Áö¼ÓÀÛ¿ëÀν¶¸°
  • non-insulin-dependent diabetes
    ºñÀν¶¸°ÀÇÁ¸´ç´¢º´
  • NPH insulin
    NPHÀν¶¸°
  • purified insulin
    ¼ø¼öÀν¶¸°, Á¤Á¦Àν¶¸°
  • regular insulin
    ¼ÓÈ¿Àν¶¸°, ºü¸¥ÀÛ¿ëÀν¶¸°
  • suppressive insulin
    ¾ïÁ¦Àν¶¸°
  • short acting insulin
    ´Ü±âÀÛ¿ëÀν¶¸°
  • disease free survival
    ¹«º´»ýÁ¸
  • distribution-free method
    ºñºÐÆ÷¹æ¹ý
  • fat-free body mass
    Áö¹æÁ¦¿ÜüÁß
  • free
    ÀÚÀ¯-, À¯¸®-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • insulin-to-glucose ratio
    Àν¶¸°Æ÷µµ´çºñÀ²
  • long acting insulin
    Áö¼ÓÀν¶¸°
  • purified insulin
    ¼ø¼öÀν¶¸°
  • short acting insulin
    ´Ü±âÀÛ¿ëÀν¶¸°
  • suppressive insulin
    ¾ïÁ¦Àν¶¸°
  • free acid
    À¯¸®»ê
  • free association
    ÀÚÀ¯¿¬»ó
  • free fatty acid
    À¯¸®Áö¹æ»ê
  • free floating anxiety
    ¶°µ¹À̺ҾÈ
  • free joint articulator
    ÀÚÀ¯¿îµ¿±³ÇÕ±â
  • free-living ameba
    ÀÚÀ¯»ýȰ¾Æ¸Þ¹Ù
  • specific pathogen free animal
    ƯÁ¤¹«º´¿øÃ¼µ¿¹°
  • free border
    ÀÚÀ¯¸ð¼­¸®
  • free-air chamber
    ÀÚÀ¯°ø±âÇÔ
  • free-living cycle
    ÀÚÀ¯»ýȰ°í¸®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • insulin sensitivity index
    Àν¶¸°°¨¼ºÁö¼ö.
  • insulin sensitivity test
    Àν¶¸°°¨¼º½ÃÇè.
  • insulin shock
    Àν¶¸°¼ï.
  • insulin shock therapy
    Àν¶¸°¼ï¿ä¹ý.
  • insulin shock treatment
    Àν¶¸°Ãæ°ÝÄ¡·á.
  • insulin test
    Àν¶¸°½ÃÇè.
  • insulin therapy
    Àν¶¸°Ä¡·á, Àν¶¸°¿ä¹ý.
  • insulin tolerance
    Àν¶¸°³»¼º.
  • insulin tolerance test
    Àν¶¸°³»¼º½ÃÇè.
  • insulin tolerance test
    Àν¶¸°³»¼º½ÃÇè
  • protamin insulin(e)
    ÇÁ·ÎŸ¹ÎÀν¶¸°.
  • protamin(e) insulin
    ÇÁ·ÎŸ¹ÎÀν¶¸°.
  • protamin(e) zinc insulin
    ÇÁ·ÎŸ¹Î¾Æ¿¬ Àν¶¸°.
  • protamin(e) zinc insulin
    ÇÁ·ÎŸ¹Î¾Æ¿¬ Àν¶¸°.
  • FFA (free fatty acids)
    À¯¸®(ë´×î)Áö¹æ»ê(ò·Û¸ß«)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • insulin antagonist
    Àν¶¸°±æÇ×ü.
  • insulin antagonist
    Àν¶¸°±æÇ×Á¦.
  • insulin antiserum
    Ç×Àν¶¸°Ç÷û.
  • insulin coma therapy
    Àν¶¸° È¥¼ö Ä¡·á
  • insulin convulsive therapy combined
    Àν¶¸°°æ·Ãº´ÇÕÄ¡·á<¿ä¹ý>
  • insulin convulsive therapy combined
    Àν¶¸°°æ·Ãº´ÇÕÄ¡·á<¿ä¹ý>.
  • insulin deficiency diabetes
    Àν¶¸°°áÇ̼º ´ç´¢º´.
  • insulin dependence
    Àν¶¸°ÀÇÁ¸¼º.
  • insulin dependent diabetes mellitus =IDDM
    Àν¶¸°ÀÇÁ¸¼º ´ç´¢º´.
  • insulin edema
    Àν¶¸°ºÎÁ¾(¡­Ý©ðþ).
  • insulin like activity =ILa
    Àν¶¸°¾çȰ¼º(ÀÛ¿ë).
  • insulin lipodystrophy
    Àν¶¸°Áö¹æÀÌ¿µ¾çÁõ.
  • insulin receptor
    Àν¶¸°¼ö¿ëü.
  • insulin receptor
    Àν¶¸°¼ö¿ëü(áôé»ô÷).
  • insulin resistance
    Àν¶¸°ÀúÇ×¼º.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • suppressible insulin-like activity
    ¾ï¾Ð °¡´É(åääâʦÒö) Àν¶¸°À¯»çȰ¼º(×¾ÞÄüÀàõ)
  • cell-free amino acid incorporating system
    ¹«¼¼Æ÷(Ùíá¬øà) ¾Æ¹Ì³ë»ê ÆíÀÔ(øºìý)¾¾½ºÅÛ
  • cell-free extract
    ¹«¼¼Æ÷ÃßÃâ¹°(Ùíá¬øàõÎõóÚª)
  • cell-free protein synthesis
    ¹«¼¼Æ÷´Ü¹éÁúÇÕ¼º(Ùíá¬øàÓ±ÛÜòõùêà÷)
  • cell-free system
    ¹«¼¼Æ÷(Ùíá¬øà)½Ã½ºÅÛ
  • free calcium
    À¯¸®(ë´×î) Ä®½·
  • free diffusion
    ÀÚÀ¯ È®»ê(í»ë¦üªß¤)
  • free electrophoresis
    ÀÚÀ¯ Àü±â¿µµ¿(í»ë¦ï³Ñ¨ç¶ÔÑ)
  • free energy
    ÀÚÀ¯(í»ë¦) ¿¡³ÊÁö
  • free energy change
    ÀÚÀ¯(í»ë¦) ¿¡³ÊÁö º¯È­(ܨûù)
  • free fatty acids
    À¯¸® Áö¹æ»ê(ë´×îò·Û¸ß«)
  • free radical
    ÀÚÀ¯(í»ë¦) ·¡µðÄ®
  • free rotation
    ÀÚÀ¯ ȸÀü(í»ë¦üÞï®)
  • germ-free animal
    ¹«±Õµ¿¹°(ÙíжÔÑÚª)
  • Gibbs free energy
    ±é½º ÀÚÀ¯(í»ë¦)¿¡³ÊÁö
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • free-flowing effusion
    ÀÚÀ¯À¯µ¿»ïÃâ¾×
  • free-hand technique
    ¼Õ±â¹ý
  • oxidative free radical
    »êÈ­ÀÚÀ¯±â
  • oxygen free radical
    »ê¼ÒÀÚÀ¯±â
  • salt-free diet
    ¹«¿°½Ä(ÀÌ)
  • SSFP [=steady state free precession]
    Ç×Á¤»óÅÂÀÚÀ¯¼¼Â÷
  • steady state free precession [=SSFP]
    Ç×Á¤»óÅÂÀÚÀ¯¼¼Â÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GF gastric fistula; gastric fluid; germ-free; glass factor; glomerular filtration; gluten-free; grandfa...
SFH schizophrenia family history; serum-free hemoglobin; stroma-free hemoglobin
GFI glucagon-free insulin; goodness-of-fit index; ground-fault interrupter
NPH   1) Neutral Protamine Hagedorn Insulin
    = Isophane Insulin Susp...
AITT arginine insulin tolerance test; augmented insulin tolerance test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CFS Cell-free supernatant
DFS Disease free
DFI Disease free interval
DFS Disease free survival
DDFS Distant disease-free survival
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • free associatoin
    ÀÚÀ¯ ¿¬»ó
  • free body
    À¯¸® ü
  • free coagulase
    À¯¸® ÄÚ¾Æ±Ö À¯¸® Ç÷Àå ÀÀ°í È¿¼Ò
  • free edge
    ÀÚÀ¯ º¯¿¬ºÎ
  • free end saddle partial denture
    À¯¸®´Ü ±¹ºÎ ÀÇÄ¡
    ¾Ç±ÃÀÇ ÈĹ濡 ÀÜÁ¸Ä¡°¡ ÆíÃø ¶Ç´Â ¾çÃø¼ºÀ¸·Î ¾øÀ» ¶§ Á¦ÀÛµÈ ±¹¼Ò ÀÇÄ¡ÀÌ´Ù.
  • free equilibrium
    ÀÚÀ¯ ÆòÇü
  • free fatty acid
    À¯¸® Áö¹æ»ê
  • free gingival margin
    À¯¸® Ä¡Àº¿¬
  • free grafting
    À¯¸® À̽Ä, À¯¸® À̽ļú
  • free induction decay
    ÀÚÀ¯ À¯µµ ºØ±«
  • free interval
    ¹«Áõ»ó±â
  • free joint articulator
    ÀÚÀ¯ ¿îµ¿ ±³ÇÕ±â
  • free lip area
    À¯¸® ±¸¼ø ºÎÀ§
  • free mandibular movement
    ÇÏ¾Ç ÀÚÀ¯ ¿îµ¿, ÀÚÀ¯ ÇϾǰñ ¿îµ¿
  • free nerve ending
    ÀÚÀ¯ ½Å°æ Á¾¸», À¯¸® ½Å°æ Á¾¸»
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
mean free path <radiobiology> Average distance a particle travels between occurrences of the given event, for example, between collisions. For collisions, the mean free path is roughly equal to unity divided by the product of the collision cross-section times the particle density.
(09 Oct 1997)
regular insulin A rapidly acting form of insulin which is a clear solution and may be administered intravenously as well as subcutaneously; may be mixed with longer acting forms of insulin to extend the duration of effect. Onset of effect occurs in 1/2 to 1 hour, peak effects are observed in 2 to 3 hours, and the duration of effect is about 5 to 7 hours.
Synonym: globin insulin.
(05 Mar 2000)
regular insulin injection A preparation that may contain 20, 40, 80, 100, or 500 USP insulin units per ml, although the trend is toward standardizing all insulin preparations at 100 units per ml; it is administered subcutaneously, occasionally intravenously, and has a rapid onset of action, has a brief duration (5 to 7 hours), and is compatible for mixing with long-acting insulin preparations; used in the treatment of diabetic acidosis and insulin coma.
Synonym: regular insulin injection.
(05 Mar 2000)
globin insulin A rapidly acting form of insulin which is a clear solution and may be administered intravenously as well as subcutaneously; may be mixed with longer acting forms of insulin to extend the duration of effect. Onset of effect occurs in 1/2 to 1 hour, peak effects are observed in 2 to 3 hours, and the duration of effect is about 5 to 7 hours.
Synonym: globin insulin.
(05 Mar 2000)
globin zinc insulin A sterile solution of insulin modified by the addition of zinc chloride and globin; it contains 40 or 80 units per ml; duration of action is about 18 hours.
Human insulin, a protein that has the normal structure of insulin produced by the human pancreas, prepared by recombinant DNA techniques and by semisynthetic processes.
Immunoreactive insulin (IRI), that portion of insulin in blood measured by immunochemical methods for the hormone; presumed to represent the free (unbound) and biologically active fraction of total blood insulin.
Isophane insulin, a modified form of insulin composed of insulin, protamine, and zinc; an intermediately acting preparation used for the treatment of diabetes mellitus.
Synonym: NPH insulin.
(05 Mar 2000)
cell-free extract <cell culture> A liquid that is a mixture of the contents of a particular type of cell, sometimes the organelles are also filtered out of the liquid.
(26 Mar 1998)
cell-free protein synthesis <technique> An in vitro method to make proteins, using amino acids, the mRNA corresponding to the protein to be made, and a cell-free extract (the contents of a cell after removal of the cell wall and/or outer cell membranes) for other needed components and enzymes.
(26 Mar 1998)
cell-free system <cell culture, molecular biology> Any system in which a normal cellular reaction is reconstituted in the absence of cells for example in vitro translation systems that will synthesise protein from mRNA using a lysate of rabbit reticulocytes or wheat germ.
A fractionated cell extract that maintains a biological function. A subcellular fraction isolated by ultracentrifugation or other separation techniques must first be isolated so that a process can be studied free from all of the complex side reactions that occur in a cell. The cell-free system is therefore widely used in cell biology.
(12 Dec 1998)
gluten-free diet Elimination of all wheat, rye, barley, and oat gluten from the diet; treatment for gluten-sensitive enteropathy (coeliac disease).
See: coeliac disease.
(05 Mar 2000)
working distance free <microscopy> The distance between the front lens of the objective and the coverslip (or uncovered object) when the lens is focused on the specimen.
(05 Aug 1998)
crystalline insulin zinc suspension A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours.
Synonym: crystalline insulin zinc suspension.
(05 Mar 2000)
culture media, serum-free Culture media free of serum proteins but including the minimal essential substances required for cell growth. This type of medium avoids the presence of extraneous substances that may affect cell proliferation or unwanted activation of cells.
(12 Dec 1998)
prompt insulin zinc suspension Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection.
Synonym: amorphous insulin zinc suspension, semilente insulin.
(05 Mar 2000)
protamine zinc insulin Insulin modified by the addition of protamine and zinc chloride; it contains 40 or 80 units per ml.
(05 Mar 2000)
semilente insulin Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection.
Synonym: amorphous insulin zinc suspension, semilente insulin.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • caffeine-free
    Ä«ÆäÀÎ ¾ø´Â
  • carriage free
    ¿îÀÓ ¹ß¼ÛÀÎ ÁöºÒ·á;¿îÀÓ ¹«·á·Î
  • customs-free
    ¹«°ü¼¼ÀÇ
  • european free trade association
    À¯·´ÀÚÀ¯¹«¿ª¿¬ÇÕ
  • free
    ÀÚÀ¯·Î¿î;ÀÚÁÖÀûÀÎ;ºÐ¹æÇÑ;¼ÖÁ÷ÇÑ;±ÔÄ¢¿¡ ±¸¾ÖµÇÁö ¾Ê´Â;ÇѰ¡ÇÑ;°íÁ¤µÇ¾î ÀÖÁö¾ÊÀº;ÀÚÀ¯·Ó°Ô;¹«·á·Î;(»ç¶÷À») ÀÚÀ¯ÀÇ ¸öÀ¸·Î ÇÏ´Ù
  • free agent
    ÀÚÁÖÀûÀÎ ÇàÀ§ÀÚ;ÀÚÀ¯°è¾à ¼±¼ö )
  • free air
    ÀÚÀ¯´ë±â
  • free alongside ship
    ¼öÃâÇ× ¼±Ãøµµ·Î
  • free alongside vessel
    ¼öÃâÇ× ¼±Ãøµµ·Î
  • free association
    ÀÚÀ¯ ¿¬»ó(¹ý)
  • free atmosphere
    ÀÚÀ¯´ë±â
  • free baggage allowance
    ¹«·á ¼öÇϹ° Çã¿ë Áß·®
  • free ball
    ÇÁ¸®º¼
  • free base
    ÇÁ¸® º£À̽º(ÄÚÄ«Àΰú ¿¡Å׸£ÀÇ È¥ÇÕ¹°)
  • free city
    ÀÚÀ¯½Ã(µ¶¸³ ±¹°¡·Î µÈ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á